{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:43:55Z","timestamp":1788389035040,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404019"],"award-info":[{"award-number":["82404019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wuhan Natural Science Foundation Exploration Plan","award":["2024040801020365"],"award-info":[{"award-number":["2024040801020365"]}]},{"name":"Hubei Provincial Natural Science Foundation of China","award":["2025AFB927"],"award-info":[{"award-number":["2025AFB927"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05152-4","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T19:52:36Z","timestamp":1777751556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A tumor microenvironment-focused signature based on m6A and lactylation modification predicts prognosis and immunotherapy response in hepatocellular carcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Shaohui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"3","key":"5152_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.gendis.2020.01.014","volume":"7","author":"W Wang","year":"2020","unstructured":"Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020;7(3):308\u201319.","journal-title":"Genes Dis"},{"issue":"7747","key":"5152_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","volume":"567","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Sun A, Zhao Y, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature. 2019;567(7747):257\u201361.","journal-title":"Nature"},{"issue":"1","key":"5152_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"7","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;7(1):35.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"5152_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","volume":"20","author":"C Yang","year":"2023","unstructured":"Yang C, Zhang H, Zhang L, et al. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2023;20(4):203\u201322.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7779","key":"5152_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature Oct"},{"issue":"2","key":"5152_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.chembiol.2019.11.005","volume":"20","author":"DO Gaffney","year":"2020","unstructured":"Gaffney DO, Jennings EQ, Anderson CC, et al. Non-enzymatic lysine lactoylation of glycolytic enzymes. Cell Chem Biol. 2020;20(2):206\u201313. e206.","journal-title":"Cell Chem Biol"},{"issue":"3","key":"5152_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41575-023-00746-7","volume":"20","author":"E Kotsiliti","year":"2023","unstructured":"Kotsiliti E. Lactylation and HCC progression. Nat Rev Gastroenterol Hepatol. 2023;20(3):131.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5152_CR8","doi-asserted-by":"publisher","first-page":"1253064","DOI":"10.3389\/fimmu.2023.1253064","volume":"14","author":"J Su","year":"2023","unstructured":"Su J, Zheng Z, Bian C, et al. Functions and mechanisms of lactylation in carcinogenesis and immunosuppression. Front Immunol. 2023;14:1253064.","journal-title":"Front Immunol"},{"issue":"1","key":"5152_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-023-01856-1","volume":"8","author":"B Xie","year":"2023","unstructured":"Xie B, Lin J, Chen X, et al. CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. Mol Cancer. 2023;8(1):151.","journal-title":"Mol Cancer"},{"issue":"Pt B","key":"5152_CR10","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.ijbiomac.2022.10.014","volume":"1","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yang Z, Yu Y, Zhang P. HIF1alpha lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer. Int J Biol Macromol. 2022;1(Pt B):2225\u201343.","journal-title":"Int J Biol Macromol"},{"key":"5152_CR11","doi-asserted-by":"publisher","first-page":"115477","DOI":"10.1016\/j.biopha.2023.115477","volume":"167","author":"D Wang","year":"2023","unstructured":"Wang D, Zhang Y, Li Q, et al. N6-methyladenosine (m6A) in cancer therapeutic resistance: potential mechanisms and clinical implications. Biomed Pharmacother. 2023;167:115477.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"5152_CR12","doi-asserted-by":"publisher","first-page":"e1460","DOI":"10.1002\/ctm2.1460","volume":"13","author":"ZM Zhu","year":"2023","unstructured":"Zhu ZM, Huo FC, Zhang J, Shan HJ, Pei DS. Crosstalk between m6A modification and alternative splicing during cancer progression. Clin Transl Med. 2023;13(10):e1460.","journal-title":"Clin Transl Med"},{"key":"5152_CR13","doi-asserted-by":"publisher","first-page":"132582","DOI":"10.1016\/j.jhazmat.2023.132582","volume":"5","author":"P Wang","year":"2024","unstructured":"Wang P, Xie D, Xiao T, et al. H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1\/m6A\/NREP. J Hazard Mater. 2024;5:461:132582.","journal-title":"J Hazard Mater"},{"issue":"1","key":"5152_CR14","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","volume":"20","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B, et al. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;20(1):6523.","journal-title":"Nat Commun"},{"issue":"9","key":"5152_CR15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"5","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, et al. Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;5(9):1660\u201377. e1610.","journal-title":"Mol Cell"},{"issue":"33","key":"5152_CR16","doi-asserted-by":"publisher","first-page":"e06529","DOI":"10.1002\/advs.202506529","volume":"12","author":"T Huang","year":"2025","unstructured":"Huang T, You Q, Liu J, et al. WTAP mediated m6A modification stabilizes PDIA3P1 and promotes tumor progression driven by histone lactylation in esophageal squamous cell carcinoma. Adv Sci (Weinh). 2025;12(33):e06529.","journal-title":"Adv Sci (Weinh)"},{"key":"5152_CR17","doi-asserted-by":"publisher","first-page":"102001","DOI":"10.1016\/j.tranon.2024.102001","volume":"46","author":"Z Gui","year":"2024","unstructured":"Gui Z, Ye Y, Li Y, et al. Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in cervical cancer. Transl Oncol. 2024;46:102001.","journal-title":"Transl Oncol"},{"issue":"1","key":"5152_CR18","doi-asserted-by":"publisher","first-page":"21565","DOI":"10.1038\/s41598-023-48653-w","volume":"7","author":"Y Ye","year":"2023","unstructured":"Ye Y, Zhang S, Jiang Y, et al. Identification of a cancer associated fibroblasts-related index to predict prognosis and immune landscape in ovarian cancer. Sci Rep. 2023;7(1):21565.","journal-title":"Sci Rep"},{"key":"5152_CR19","doi-asserted-by":"crossref","unstructured":"Cheng Z, Huang H, Li M, Liang X, Tan Y, Chen Y. Lactylation-related gene signature effectively predicts prognosis and treatment responsiveness in hepatocellular carcinoma. Pharmaceuticals (Basel). 2023;16(5).","DOI":"10.3390\/ph16050644"},{"issue":"3","key":"5152_CR20","doi-asserted-by":"publisher","first-page":"eabi6696","DOI":"10.1126\/sciadv.abi6696","volume":"21","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, Zhang D, Wei W, et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 2022;21(3):eabi6696.","journal-title":"Sci Adv"},{"key":"5152_CR21","doi-asserted-by":"publisher","first-page":"215749","DOI":"10.1016\/j.canlet.2022.215749","volume":"10","author":"H Ren","year":"2022","unstructured":"Ren H, Chen Y, Ao Z, et al. PDE4D binds and interacts with YAP to cooperatively promote HCC progression. Cancer Lett. 2022;10:541:215749.","journal-title":"Cancer Lett"},{"issue":"5930","key":"5152_CR22","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"22","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;22(5930):1029\u201333.","journal-title":"Science"},{"key":"5152_CR23","doi-asserted-by":"crossref","unstructured":"Chen L, Huang L, Gu Y, Cang W, Sun P, Xiang Y. Lactate-lactylation hands between metabolic reprogramming and immunosuppression. Int J Mol Sci. 2022;23(19).","DOI":"10.3390\/ijms231911943"},{"issue":"12","key":"5152_CR24","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1080\/15548627.2023.2246356","volume":"19","author":"W Sun","year":"2023","unstructured":"Sun W, Jia M, Feng Y, Cheng X. Lactate is a bridge linking glycolysis and autophagy through lactylation. Autophagy. 2023;19(12):3240\u20131.","journal-title":"Autophagy Dec"},{"key":"5152_CR25","doi-asserted-by":"publisher","first-page":"103194","DOI":"10.1016\/j.redox.2024.103194","volume":"74","author":"D Wu","year":"2024","unstructured":"Wu D, Spencer CB, Ortoga L, Zhang H, Miao C. Histone lactylation-regulated METTL3 promotes ferroptosis via m6A-modification on ACSL4 in sepsis-associated lung injury. Redox Biol Aug. 2024;74:103194.","journal-title":"Redox Biol Aug"},{"issue":"47","key":"5152_CR26","doi-asserted-by":"publisher","first-page":"e14008","DOI":"10.1002\/advs.202514008","volume":"12","author":"JN Tan","year":"2025","unstructured":"Tan JN, Yu JH, Hou D, et al. Extracellular vesicle-packaged circTAX1BP1 from cancer-associated fibroblasts regulates RNA m6A modification through lactylation of VIRMA in colorectal cancer cells. Adv Sci (Weinh). 2025;12(47):e14008.","journal-title":"Adv Sci (Weinh)"},{"issue":"46","key":"5152_CR27","doi-asserted-by":"publisher","first-page":"e2401399","DOI":"10.1002\/advs.202401399","volume":"11","author":"Y Lu","year":"2024","unstructured":"Lu Y, Zhu J, Zhang Y, et al. Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC. Adv Sci (Weinh). 2024;11(46):e2401399.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"5152_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.annonc.2023.10.124","volume":"34","author":"T Fulton-Ward","year":"2023","unstructured":"Fulton-Ward T, Middleton G. The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review. Ann Oncol. 2023;34(12):1113\u201330.","journal-title":"Ann Oncol"},{"key":"5152_CR29","doi-asserted-by":"crossref","unstructured":"Huang Y, Chau YF, Bai H, Wu X, Duan J. Biomarkers for immunotherapy in driver-gene-negative advanced NSCLC. Int J Mol Sci Sep 25 2023;24(19).","DOI":"10.3390\/ijms241914521"},{"issue":"1","key":"5152_CR30","doi-asserted-by":"publisher","first-page":"42530","DOI":"10.1038\/s41598-025-26956-4","volume":"27","author":"W Wang","year":"2025","unstructured":"Wang W, Wang E, Hong K, et al. m6A regulators-based gene expression pattern is associated with immune microenvironment characteristics in hepatocellular carcinoma. Sci Rep. 2025;27(1):42530.","journal-title":"Sci Rep Nov"},{"issue":"4","key":"5152_CR31","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41375-022-01510-7","volume":"36","author":"Z Wen","year":"2022","unstructured":"Wen Z, Finn R, Gao X, et al. Tcof1 haploinsufficiency promotes early T cell precursor-like leukemia in Nras(Q61R\/+) mice. Leukemia. 2022;36(4):1167\u201370.","journal-title":"Leukemia Apr"},{"issue":"1","key":"5152_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41416-021-01596-3","volume":"126","author":"J Hu","year":"2022","unstructured":"Hu J, Lai Y, Huang H, et al. TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis. Br J Cancer. 2022;126(1):57\u201371.","journal-title":"Br J Cancer Jan"},{"issue":"3","key":"5152_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s13167-023-00335-3","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li N, Yang L, et al. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach. EPMA J. 2023;14(3):477\u2013502.","journal-title":"EPMA J"},{"issue":"2","key":"5152_CR34","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/cas.15242","volume":"113","author":"C Wu","year":"2022","unstructured":"Wu C, Xia D, Wang D, et al. TCOF1 coordinates oncogenic activation and rRNA production and promotes tumorigenesis in HCC. Cancer Sci. 2022;113(2):553\u201364.","journal-title":"Cancer Sci Feb"},{"issue":"8","key":"5152_CR35","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1093\/cvr\/cvab198","volume":"29","author":"LS Dunaway","year":"2022","unstructured":"Dunaway LS, Pollock JS. HDAC1: an environmental sensor regulating endothelial function. Cardiovasc Res. 2022;29(8):1885\u2013903.","journal-title":"Cardiovasc Res"},{"key":"5152_CR36","doi-asserted-by":"publisher","first-page":"102379","DOI":"10.1016\/j.jaut.2019.102379","volume":"108","author":"L Goschl","year":"2020","unstructured":"Goschl L, Preglej T, Boucheron N, et al. Histone deacetylase 1 (HDAC1): a key player of T cell-mediated arthritis. J Autoimmun. 2020;108:102379.","journal-title":"J Autoimmun Mar"},{"issue":"7","key":"5152_CR37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/cdd.2016.31","volume":"23","author":"P Ma","year":"2016","unstructured":"Ma P, Schultz RM. HDAC1 and HDAC2 in mouse oocytes and preimplantation embryos: specificity versus compensation. Cell Death Differ. 2016;23(7):1119\u201327.","journal-title":"Cell Death Differ"},{"issue":"1","key":"5152_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4068\/cmj.2016.52.1.1","volume":"52","author":"S Yoon","year":"2016","unstructured":"Yoon S, Eom GH, HDAC, Inhibitor HDAC. From cancer to cardiovascular diseases. Chonnam Med J. 2016;52(1):1\u201311.","journal-title":"Chonnam Med J"},{"issue":"2","key":"5152_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2337\/db23-0360","volume":"1","author":"J Sun","year":"2024","unstructured":"Sun J, Wang Y, Fu H, et al. Mettl3-mediated m6A methylation controls pancreatic bipotent progenitor fate and islet formation. Diabetes. 2024;1(2):237\u201349.","journal-title":"Diabetes"},{"key":"5152_CR40","doi-asserted-by":"crossref","unstructured":"Li Y, Seto E. HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb Perspect Med 2016;6(10).","DOI":"10.1101\/cshperspect.a026831"},{"issue":"1","key":"5152_CR41","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12885-021-08388-1","volume":"29","author":"RC Ramaker","year":"2021","unstructured":"Ramaker RC, Hardigan AA, Gordon ER, Wright CA, Myers RM, Cooper SJ. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition. BMC Cancer. 2021;29(1):632.","journal-title":"BMC Cancer"},{"key":"5152_CR42","doi-asserted-by":"publisher","first-page":"700947","DOI":"10.3389\/fonc.2021.700947","volume":"11","author":"R Hai","year":"2021","unstructured":"Hai R, He L, Shu G, Yin G. Characterization of histone deacetylase mechanisms in cancer development. Front Oncol. 2021;11:700947.","journal-title":"Front Oncol"},{"issue":"21","key":"5152_CR43","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1002\/cncr.34974","volume":"1","author":"R Parveen","year":"2023","unstructured":"Parveen R, Harihar D, Chatterji BP. Recent histone deacetylase inhibitors in cancer therapy. Cancer. 2023;1(21):3372\u201380.","journal-title":"Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05152-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:02:47Z","timestamp":1781881367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05152-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5152"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05152-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"927"}}